Ticker Details
Heron Therapeutics, Inc. Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.
IPO Date:	January 23, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$162.55M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 3.11%
Avg Daily Range (30 D):	$0.04 | 3.63%
Avg Daily Range (90 D):	$0.03 | 3.14%

Institutional Daily Volume
Avg Daily Volume:	1.29M
Avg Daily Volume (30 D):	2.25M
Avg Daily Volume (90 D):	1.79M

Trade Size
Avg Trade Size (Sh.):	167
Avg Trade Size (Sh.) (30 D):	279
Avg Trade Size (Sh.) (90 D):	314

Institutional Trades
Total Institutional Trades:	3,473
Avg Institutional Trade:	$1.58M
Avg Institutional Trade (30 D):	$.5M
Avg Institutional Trade (90 D):	$1.54M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.03M
Avg Closing Trade (30 D):	$1.57M
Avg Closing Trade (90 D):	$1.57M
Avg Closing Volume:	180.87K

News

Oct 29, 2025 @ 9:58 PM Heron Therapeutics Announces Appointment of Thomas... Source: Craig Collard

Oct 29, 2024 @ 8:05 PM Heron Therapeutics to Report Third Quarter 2024 Fi... Source: Prnewswire

Sep 17, 2024 @ 10:00 AM Chemotherapy Induced Nausea and Vomiting Treatment... Source: Fact.Mr

Jul 2, 2024 @ 12:43 PM Merck (MRK) Gets Exclusive Rights to Opevesostat F... Source: Zacks Equity Research

Jul 1, 2024 @ 2:31 PM FDA Rejects Rocket's (RCKT) Gene Therapy BLA for R... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.17	$-.04	$-.01
Diluted EPS	$-.17	$-.04	$-.01
Revenue	$150.71M	$34.71M	$40.59M
Gross Profit	$107.18M	$24.07M	$29.47M
Net Income / Loss	$-30.94M	$-8.11M	$-2.95M
Operating Income / Loss	$-10.46M	$-4.77M	$.04M
Cost of Revenue	$43.53M	$10.64M	$11.12M
Net Cash Flow	$6.85M	$-2.53M	$-14.42M
PE Ratio

Splits
Jan 13, 2014	1:20
May 25, 2007	1:4